tiprankstipranks
MaaT Pharma (FR:MAAT)
:MAAT
France Market
MAAT
MaaT Pharma
RESEARCH TOOLSreports

MaaT Pharma (MAAT) Income Statement

3 Followers

MaaT Pharma Income Statement

Last quarter (Q4 2025), MaaT Pharma's total revenue was €2.10M, an increase of 146.71% from the same quarter last year. In Q4, MaaT Pharma's net income was €-15.98M. See MaaT Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 4.52M€ 3.22M€ 2.23M€ 1.43M€ 972.00K
Gross Profit
€ 1.39M€ 1.97M€ 784.00K€ 1.09M€ 806.00K
Operating Expenses
€ 35.54M€ 30.39M€ 25.39M€ 14.65M€ 9.70M
Depreciation and Amortization
€ 1.74M€ 1.69M€ 871.00K€ 429.00K€ 328.00K
EBITDA
€ -32.41M€ -26.34M€ -22.07M€ -13.10M€ -8.57M
Operating Income
€ -34.15M€ -28.43M€ -19.94M€ -13.56M€ -8.89M
Other Income/Expenses
€ -705.00K€ -3.99M€ 226.00K€ -156.00K€ -126.00K
Pretax Income
€ -34.85M€ -32.42M€ -19.72M€ -13.71M€ -9.02M
Net Income
€ -31.06M€ -28.90M€ -19.72M€ -13.71M€ -9.02M
Per Share Metrics
Basic EPS
€ -1.95€ -2.20€ -1.73€ -1.39€ -3.72
Diluted EPS
€ -1.95€ -2.20€ -1.73€ -1.39€ -3.72
Weighted Average Shares Outstanding
 15.93M 13.06M 11.37M 9.89M 2.43M
Weighted Average Shares Outstanding (Diluted)
 15.93M 13.06M 11.37M 9.89M 2.43M
Currency in EUR

MaaT Pharma Earnings and Revenue History